CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways
Open Access
- 1 October 2016
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 90 (4) , 483-495
Abstract
The G protein-coupled receptor (GPCR) C-X-C chemokine receptor 3 (CXCR3) is a potential drug target that mediates signaling involved in cancer metastasis and inflammatory diseases. The CXCR3 primary transcript has three potential alternative splice variants and cell-type specific expression results in receptor variants that are believed to have different functional characteristics. However, the molecular pharmacology of ligand binding to CXCR3 alternative splice variants and their downstream signaling pathways remain poorly explored. To better understand the role of the functional consequences of alternative splicing of CXCR3, we measured signaling in response to four different chemokine ligands (CXCL4, CXCL9, CXCL10, and CXCL11) with agonist activity at CXCR3. Both CXCL10 and CXCL11 activated splice variant CXCR3A. Whereas CXCL10 displayed full agonistic activity for Gαi activation and extracellular signal regulated kinase (ERK) 1/2 phosphorylation and partial agonist activity for β-arrestin recruitment, CXCL9 triggered only modest ERK1/2 phosphorylation. CXCL11 induced CXCR3B-mediated β-arrestin recruitment and little ERK phosphorylation. CXCR3Alt signaling was limited to modest ligand-induced receptor internalization and ERK1/2 phosphorylation in response to chemokines CXCL11, CXCL10, and CXCL9. These results show that CXCR3 splice variants activate different signaling pathways and that CXCR3 variant function is not redundant, suggesting a mechanism for tissue specific biased agonism. Our data show an additional layer of complexity for chemokine receptor signaling that might be exploited to target specific CXCR3 splice variants.Keywords
This publication has 53 references indexed in Scilit:
- Analysis of Arrestin Recruitment to Chemokine Receptors by Bioluminescence Resonance Energy Transfer2015
- Different Effects of the Different Natural CC Chemokine Receptor 2b Ligands on β-Arrestin Recruitment, Gαi Signaling, and Receptor InternalizationMolecular Pharmacology, 2011
- Control of Chemokine-Guided Cell Migration by Ligand SequestrationCell, 2008
- Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signalingNeuropharmacology, 2008
- β-Arrestins and Cell SignalingAnnual Review of Physiology, 2007
- Direct Assessment of CXCR4 Mutant Conformations Reveals Complex Link between Receptor Structure and Gαi ActivationJournal of Biological Chemistry, 2007
- CXCR3 Requires Tyrosine Sulfation for Ligand Binding and a Second Extracellular Loop Arginine Residue for Ligand-Induced ChemotaxisMolecular and Cellular Biology, 2006
- CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Intracellular Domains of CXCR3 That Mediate CXCL9, CXCL10, and CXCL11 FunctionJournal of Biological Chemistry, 2004
- Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.Proceedings of the National Academy of Sciences, 1994